HR 4702
118th Congress
House
Health
Administrative law and regulatory procedures
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Genetics
Health technology, devices, supplies
Medical research
Research administration and funding
Securing Gene Synthesis Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 21, 2023
Referred to the Subcommittee on Health.
Jul 18, 2023
Introduced in House
Jul 18, 2023
Referred to the House Committee on Energy and Commerce.
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Securing Gene Synthesis Act
This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
What's happening now
Referred to the Subcommittee on Health.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
2
Cite this page
U.S. Congress. (2026). H.R. 4702: Securing Gene Synthesis Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4702/
"H.R. 4702: Securing Gene Synthesis Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4702/.
H.R. 4702, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4702/.
[H.R. 4702: Securing Gene Synthesis Act](https://openamerica.io/bill/118-HR-4702/)